J. Thornhill

发表

Incoming HIV virion-derived Gag Spacer Peptide 2 (p1) is a target of effective CD8+ T cell antiviral responses.

C. Brander, V. Miller, T. Peto, 2021, Cell reports.

Clinical outcomes of patients with and without HIV hospitalized with COVID‐19 in England during the early stages of the pandemic: a matched retrospective multi‐centre analysis (RECEDE‐C19 study)

J. Fox, M. Wiselka, L. Goodwin, 2021, HIV medicine.

Brief Report: Enhanced Normalization of CD4/CD8 Ratio With Earlier Antiretroviral Therapy at Primary HIV Infection

P. Kaleebu, J. Miro, D. Cooper, 2016, Journal of acquired immune deficiency syndromes.

Enhanced normalisation of CD4/CD8 ratio with early antiretroviral therapy in primary HIV infection

P. Kaleebu, D. Cooper, J. Weber, 2014, Journal of the International AIDS Society.

Enhanced Normalization of CD 4 / CD 8 Ratio With Earlier Antiretroviral Therapy at Primary HIV Infection

P. Kaleebu, J. Miro, D. Cooper, 2022 .

The Role of CD4+ T Follicular Helper Cells in HIV Infection: From the Germinal Center to the Periphery

P. Klenerman, J. Frater, S. Fidler, 2017, Front. Immunol..

British HIV Association guidelines for the management of HIV‐2 2021

I. Reeves, R. Dhairyawan, J. Thornhill, 2021, HIV medicine.

CD32 expressing doublets in HIV-infected gut-associated lymphoid tissue are associated with a T follicular helper cell phenotype

P. Klenerman, C. Willberg, C. Herrera, 2019, Mucosal Immunology.

Epigenetic Features of HIV-Induced T-Cell Exhaustion Persist Despite Early Antiretroviral Therapy

W. Haining, C. Willberg, Debattama R. Sen, 2021, Frontiers in Immunology.

A pilot evaluation of whole blood finger-prick sampling for point-of-care HIV viral load measurement: the UNICORN study

J. Frater, S. Fidler, G. Timson, 2017, Scientific Reports.

Virological Blips and Predictors of Post Treatment Viral Control After Stopping ART Started in Primary HIV Infection

C. Morrison, A. Phillips, J. Fox, 2016, Journal of acquired immune deficiency syndromes.

CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA

P. Klenerman, P. Kaleebu, C. Willberg, 2018, Front. Immunol..

Enrichment of the HIV reservoir in CD32+ CD4 T cells occurs early in blood and tissue

P. Klenerman, P. Kaleebu, C. Willberg, 2017, bioRxiv.

HIV-1 Vpr drives a tissue residency-like phenotype during selective infection of resting memory T cells

J. A. Guerra-Assunção, A. Sigal, C. Herrera, 2021, bioRxiv.

Human MAIT cells respond to and suppress HIV-1

Q. Sattentau, P. Klenerman, P. Phalora, 2021, eLife.

Impact of antiretroviral therapy in primary HIV infection on natural killer cell function and the association with viral rebound and HIV DNA following treatment interruption

J. Frater, Mathew Jones, A. Waters, 2022, Frontiers in Immunology.

Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial

M. Johnson, V. Miller, T. Peto, 2020, The Lancet.

Levels of Human Immunodeficiency Virus DNA Are Determined Before ART Initiation and Linked to CD8 T-Cell Activation and Memory Expansion

C. Willberg, J. Fox, F. Shearer, 2019, The Journal of infectious diseases.

A Randomized Comparison of Antiretroviral Therapy Alone Versus Antiretroviral Therapy with a 'Kick-and-Kill' Approach, on Measures of the HIV Reservoir Amongst Participants with Recent HIV Infection: The RIVER Trial

M. Johnson, M. Wills, A. Clarke, 2019, SSRN Electronic Journal.

HIV reservoir size is determined prior to ART initiation and linked to CD8 T cell activation and memory expansion

C. Willberg, J. Fox, F. Shearer, 2019, bioRxiv.

Post-treatment control: A functional cure for HIV

J. Frater, S. Fidler, J. Thornhill, 2015 .

Immunological biomarkers predict HIV-1 viral rebound after treatment interruption

R. Phillips, D. Cooper, C. Willberg, 2015, Nature Communications.

Advancing the HIV cure agenda: the next 5 years

J. Frater, S. Fidler, J. Thornhill, 2015, Current opinion in infectious diseases.

C URRENT OPINION Advancing the HIV cure agenda: the next 5 years

J. Frater, S. Fidler, J. Thornhill, 2015 .

OPINION Advancing the HIV cure agenda: the next 5 years

J. Frater, S. Fidler, J. Thornhill, 2015 .

Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report

J. Martinez-Picado, Ravindra K. Gupta, A. Hill, 2020, The lancet. HIV.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Vedolizumab use and the associations between α4β7 expression and HIV reservoir in the gut during treated primary HIV infection.

K. Lynch, J. Skelton, M. Dorner, 2019, AIDS.

Tolerability of four‐drug antiretroviral combination therapy in primary HIV‐1 infection

J. Fox, W. Stöhr, M. Nelson, 2021, HIV Medicine.

IAS Towards an HIV Cure Symposium: people focused, science driven

J. Ananworanich, A. Chahroudi, S. Fidler, 2015, Journal of virus eradication.

Timing of antiretrovirals in opportunistic infections

J. Thornhill, M. Aboud, 2012, International journal of STD & AIDS.

Two-drug antiretroviral regimens for HIV

R. Ferrand, J. Thornhill, J. Gaddie, 2023, BMJ.

Incoming HIV Virion-Derived Gag Spacer Peptide 2 (p1) is a Target of Effective CD8+ T Cell Antiviral Responses

C. Brander, V. Miller, T. Peto, 2020, SSRN Electronic Journal.

Advancing the HIV cure agenda: the next 5 years

J. Frater, S. Fidler, J. Thornhill, 2015, Current opinion in infectious diseases.